ASST Sette Laghi is the lead sponsor of 3 current clinical trials in our Italy register. 3 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Ropivacaine. The most-studied condition is Hemodynamic.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Three Different GHDT ( Goal Hemodynamic Directed Therapy) Strategies for Intraoperative Fluid Management Optimization During Major Abdominal Surgery: A Randomized Controlled Trial
NCT06871150 · ClinicalTrials.gov ↗ · Hemodynamic
|
Not applicable | Recruiting | 2026-03 | Italy |
|
PROPOSAL FOR A PREOPERATIVE FUNCTIONAL OPTIMIZATION PATHWAY FOR PATIENTS CANDIDATE FOR MAJOR SURGERY (CARDIAC AND ABDOMINAL ONCOLOGY)
NCT07851350 · ClinicalTrials.gov ↗ · Prehabilitation, Major Abdominal Surgeries, Cardiac Surgery
|
Observational | Recruiting | 2026-07 | Italy |
|
Anterior Suprascapular Versus Interscalene Block for Postoperative Analgesia After Arthroscopic Shoulder Surgery in the Outpatient Setting
NCT07831096 · ClinicalTrials.gov ↗ · Postoperative Pain, Acute
Drug: Ropivacaine |
Not applicable | Recruiting | 2026-01 | Italy |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Italy | 3 | 3 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Bicetre Hospital | 1 |
Sponsors with the most current trials registered for this condition.
ASST Sette Laghi is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Italy register, as of the registry sync on 2 October 2026. Completed and withdrawn studies are not counted.
Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Its current trials name 1 drug or biological as interventions. The most frequent are Ropivacaine (1). The number in brackets is how many of its trials name each drug.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 2 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.
